Firm News

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com

Cahill Represents Initial Purchasers in $1 Billion Notes Offering for Valeant Pharmaceuticals International, Inc.

Date: 10/17/17

Cahill represented the initial purchasers in connection with the Rule 144A offering of $1,000,000,000 in aggregate principal amount of 5.5% senior secured notes due 2025 by Valeant Pharmaceuticals International, Inc. Proceeds from the offering are expected to be used for refinancing existing indebtedness.

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com